Author

S. M. Leighow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Landry· 1 shared J. R. Pritchard· 1 shared M. J. Lee· 1 shared S. R. Peyton· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

B. Landry

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Agent-based models help interpret patterns of clinical drug resistance by contextualizing competition between distinct drug failure modes.

S. M. Leighow, B. Landry, M. J. Lee, S. R. Peyton, J. R. Pritchard

The paper uses agent-based models to show that microenvironmental resistance can compete with genetic resistance in tumors, explaining observed diversity in drug failure modes.

bioRxiv · Feb 25, 2022Bioengineering